Correction to: Adverse Effects of Physostigmine.

Journal

Journal of medical toxicology : official journal of the American College of Medical Toxicology
ISSN: 1937-6995
Titre abrégé: J Med Toxicol
Pays: United States
ID NLM: 101284598

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 16 8 2019
medline: 16 8 2019
entrez: 16 8 2019
Statut: ppublish

Résumé

In "Adverse Effects of Physostigmine" by Arens et al in the July 2019 issue of JMT, reference #27 contains an error.

Identifiants

DOI: 10.1007/s13181-019-00730-1 PMID: 31414401 PMC: PMC6825055
pubmed: 31414401
doi: 10.1007/s13181-019-00730-1
pii: 10.1007/s13181-019-00730-1
pmc: PMC6825055
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

310

Commentaires et corrections

Type : ErratumFor

Auteurs

Ann M Arens (AM)

Minnesota Poison Control System, Minneapolis, MN, USA. Ann.Arens@hcmed.org.
Hennepin Healthcare, Department of Emergency Medicine, Hennepin County Medical Center, 701 Park Avenue, MC-R2, Minneapolis, MN, 55415, USA. Ann.Arens@hcmed.org.

Tom Kearney (T)

California Poison Control System, San Francisco Division, San Francisco, CA, USA.
San Francisco School of Pharmacy, University of California, San Francisco, CA, USA.

Classifications MeSH